NCT04047017 2021-07-30
GTN
Peking Union Medical College Hospital
Phase 2 Completed
Clinical Trials
5 trialsNCT04476459 2021-03-15
Camrelizumab in Combination With Apatinib in Refractory and Relapsed DLBCL
Sun Yat-sen University
Phase 1/2 Unknown
NCT03913182 2020-02-05
Apatinib in the Treatment of Recurrence or Metastasis of Esophageal Cancer
Shanghai Chest Hospital
Phase 2 Unknown
NCT03376958 2019-07-25
Apatinib for Relapsed and Refractory Diffuse Large B Cell Lymphoma
Zhengzhou University
Phase 4 Completed
NCT03298074 2017-09-29
Apatinib Plus Etoposide Versus Etoposide Alone for Platinum-resistant Recurrent Ovarian Cancer
Guangxi Medical University
Phase 2 Unknown